Evidence map›Paper›PMID 34685530›Full record

ArticleCells2021

NK Cell Patterns in Idiopathic Inflammatory Myopathies with Pulmonary Affection.

Marc Pawlitzki, Christopher Nelke, Leoni Rolfes, Rebecca Hasseli, Stylianos Tomaras, Eugen Feist, Anne Schänzer, Saskia Räuber, Liesa Regner, Corinna Preuße and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Marc PawlitzkiDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, 48149 Münster, Germany.
Christopher NelkeDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, 48149 Münster, Germany.
Leoni RolfesDepartment of Neurology, University Hospital Düsseldorf, 40225 Düsseldorf, Germany.
Rebecca HasseliDepartment of Rheumatology and Clinical Immunology, Kerckhoff-Klinik GmbH, 61231 Bad Nauheim, Germany.
Stylianos TomarasDepartment of Rheumatology, Helios Fachklinik Vogelsang-Gommern, 39245 Gommern, Germany.ORCID 0000-0002-5923-2557
Eugen FeistDepartment of Rheumatology, Helios Fachklinik Vogelsang-Gommern, 39245 Gommern, Germany.ORCID 0000-0002-9872-5282
Anne SchänzerInstitute of Neuropathology, Justus Liebig University Giessen, 35392 Giessen, Germany.
Saskia RäuberDepartment of Neurology, University Hospital Düsseldorf, 40225 Düsseldorf, Germany.
Liesa RegnerDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, 48149 Münster, Germany.
Corinna PreußeDepartment of Neuropathology, Charite Medical Faculty Berlin, 13353 Berlin, Germany.
Yves AllenbachDepartment of Clinical Immunology and Internal Medicine, Sorbonne University, APHP, Pitié Salpêtrière Hospital, 75013 Paris, France.
Olivier BenvenisteDepartment of Clinical Immunology and Internal Medicine, Sorbonne University, APHP, Pitié Salpêtrière Hospital, 75013 Paris, France.
Heinz WiendlDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, 48149 Münster, Germany.
Werner StenzelDepartment of Neuropathology, Charite Medical Faculty Berlin, 13353 Berlin, Germany.
Sven G MeuthDepartment of Neurology, University Hospital Düsseldorf, 40225 Düsseldorf, Germany.
Tobias RuckDepartment of Neurology, University Hospital Düsseldorf, 40225 Düsseldorf, Germany.
Düsseldorf University Hospital · DECharité - Universitätsmedizin Berlin · DEInserm · FRJustus-Liebig-Universität Gießen · DEKerckhoff Klinik · DEUniversity Hospital Münster · DE

Funding

Bundesministerium für Bildung und Forschung 01EC1901ADeutsche Gesellschaft für Muskelkranke Ru2/1Else Kröner-Fresenius-Stiftung 2018_A03
6 · The paper itself

Abstract

backgroundPulmonary affection (PA) is associated with a substantial increase in morbidity and mortality in patients with idiopathic inflammatory myopathies (IIM). However, the underlying immune mechanisms of PA remain enigmatic and prompt deeper immunological analyses. Importantly, the Janus-faced role of natural killer (NK) cells, capable of pro-inflammatory as well as regulatory effects, might be of interest for the pathophysiologic understanding of PA in IIM.

methodsTo extend our understanding of immunological alterations in IIM patients with PA, we compared the signatures of NK cells in peripheral blood using multi-color flow cytometry in IIM patients with (

resultsWe did not observe any significant differences for B cells, CD4, and CD8 T cells, while total NK cell numbers in IIM patients with PA were reduced compared to non-PA patients. NK cell alterations were driven by a particular decrease of CD56

conclusionOur data illustrate that PA in IIM is associated with alterations of the NK cell repertoire, suggesting a relevant contribution of NK cells in certain IIMs, which might pave the way for NK cell-targeted therapeutic approaches.

Indexed as

AdultAgedAged, 80 and overFemaleHumansKiller Cells, NaturalLung Diseases, InterstitialMaleMiddle AgedMyositisantibodiesinflammatory myopathyinterstitial lung diseasemyositisnatural killer cells

Identifiers

PMID34685530
PMCPMC8534165
OpenAlexW3202848167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.